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Abstract 
In the search for new and effective prodrugs against the herpes simplex virus, a 
series of acyclovir analogues with a thiazole ring containing amino acids 
(glycine, alanine, valine, leucine) has been investigated. The chemical stability 
of some of the compounds containing different residues was studied at pH 1 
and pH 7.4 at a temperature of 37°C. An HPLC method was developed for 
quantification of the unchanged ester concentration.  
Some of the esters (Gly-thiazole, Ala-thiazole-acyclovir, Leu-thiazole-acyclovir) 
were rather unstable, especially under acidic conditions, and underwent rapid 
hydrolysis into the chemical precursor acyclovir. At pH 7.4, the stability of Val-
thiazole-acyclovir was remarkable. At this pH, Val-thiazole-acyclovir showed 
stability higher than that of valacyclovir (the first effective prodrug of acyclovir). 
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Introduction 
The discovery of the guanine analogue of acyclovir (9-[(2-hydroxyethoxy)methyl]guanine), 
ACV, set the stage for a new generation of antiviral agents [1,  2]. Along with its high 
specificity, ACV demonstrates low aqueous solubility and low bioavailability by oral 
administration (14%). To overcome this problem, several acyclovir amino acid esters have 
been synthesised. Valaciclovir, the valine ester of ACV, was found to metabolise easily by 
oral administration and possess four-fold higher bioavailability than acyclovir [3–7]. 260  G. Hristov and I Stankova:   
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Recently, we synthesised acyclovir esters with peptidomimetics and studied their antiviral 
activity against HSV-1 and HSV-2 [8–10]. 
Contrary to acyclovir esters with natural amino acids, the results showed that modification 
of acyclovir with thiazole, oxazole and thiazolyl-thiazole containing amino acids (Gly, Val, 
Ala, Leu) decreased the antiviral effect of acyclovir. The only exception with prominent 
activity against HSV-2 turned out to be the Ala-thiazolyl ester of acyclovir [8, 9]. The object 
of this study was to assess the chemical stability of some of the synthesised acyclovir 
esters with peptidomimetics at рН 1.0 and рН 7.4 at 37°С. An HPLC method was used for 
quantification of the ester concentrations [11, 12].  
Results and Discussion 
The chemical stability of acyclovir esters: Boc-2-aminomethyl-thiazole-acyclovir (1), Boc-2-
Ala-thiazole-acyclovir (2), Boc-2-Val-thiazole-acyclovir (3) and Boc-2-Leu-thiazole-
acyclovir (4) was studied under experimental conditions of biological relevance, i.e. at pH 1 
and pH 7.4, at a temperature of 37°C. The compounds were synthesised as previously 
described [8, 9]. The structures of the compounds under investigation are presented in 
Fig. 1. 
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Fig. 1.   Acyclovir esters with peptidomimetics.  
It was established that, under the described experimental conditions, some esters 
underwent decomposition by hydrolysis. The hydrolysis followed apparent first order 
kinetics, and the rate constants (K) were obtained as slopes from the semi-logarithmic 
plots of the unchanged ester concentration versus time. The chemical stability was 
assessed by means of the decomposition half-lives:   Chemical Stability of New Acyclovir Analogues with Peptidomimetics  261 
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Tab. 1.   The t½ values of the examined compounds at pH=1 and pH=7.4 
№ Compound  pH=1,  t½, h  pH=7.4, t½, h 
1 Boc-Gly(Thz)-ACV 1.1±0.1    5.9±0.5 
2 Boc-Ala(Thz)-ACV  1.3±0.1   7.8±0.5 
3 Boc-Val(Thz)-ACV 0.7±0.1  17.8±0.9 
4 Boc-Leu(Thz)-ACV 2.6±0.2   5.0±0.4 
 
Chemical stability measurements revealed that the dipeptide prodrugs of acyclovir were 
relatively unstable at acidic pH (Tab. 1, Fig. 2). Under these conditions, all of the observed 
t½ were less than 2.6 h.  
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Fig. 2.   Decrease of the concentration of the examined prodrugs at pH 1.0 (HCl) 
At pH 7.4, the Boc-2-Val-thiazole-acyclovir (3) was more stable (t1/2 = 17 h) than 
valacyclovir (t1/2 = 13 h) [3], the first effective prodrug of acyclovir, (Tab. 1, Fig. 3). 
The Boc-2-Val-thiazole-acyclovir (3) and Boc-2-aminomethyl-thiazole-acyclovir (1) were 
less stable than the Boc-2-Ala-thiazole-acyclovir (2) and Boc-2-Leu-thiazole-acyclovir (4) 
at pH 1.0. The esters (1) and (4) manifested lower stability at pH 7.4. It was found that the 
rest of compounds were stable at pH 7.4. 
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Fig. 3.   Decrease of the concentration of the examined prodrugs in buffer solution at pH 
7.4 (phosphate buffer) 
Experimental  
Chemicals 
Acetonitrile for HPLC the buffer components HCI, Na2H2PO4 of the purest grade, were 
purchased from Merck (Germany). The Grace Vidac chromatographic column was used 
(USA). 
Chromatography 
Chromatography was carried out isocratically, on a modular KNAUER HPLC system 
(Germany), consisting of a Smartline Pump 1000, a Smartline Manager 5000 solvent 
degasser, an injector with a 20 μl loop and a Smartline UV Detector 2600 diode array. The 
analyses were controlled and the data were acquired with EuroChrom software. The 
mobile phase consisted of acetonitrile/water in a ratio of 30:70 or 50:50 v/v depending on 
the polarity of the compound and a flow rate 1 ml/min was used. The detection was 
performed at relevant λmax for the respective compound (range 252–262 nm).  
Kinetic study 
A single chromatographic method was used to detect the studied acyclovir esters with 
thiazole rings containing amino acids (Gly, Ala, Val, Leu) in aqueous buffer solutions at pH 
1.0 (0.1 M HCl) and pH 7.4 (phosphate buffer). Twenty microlitres of each sample were 
injected into a reverse phase HPLC C18 column. The mobile phase consisted of 
acetonitrile/water at a ratio of 30:70 or 50:50 v/v depending on the polarity of the 
compound. The analyses of the esters of acyclovir with amino acid (Gly, Ala, Val, Leu) 
containing thiazole rings were validated. The specificity of the method was investigated by 
observing potential interference between the esters of acyclovir and its parent drug, 
acyclovir. No interfering peaks were presented in the chromatograms. The linearity of the 
relationship between the peak area and concentration was determined by analysing six 
standard solutions in a concentration range of 0.1–1.0 mmol/l. For all analytes, the 
relationship between the peak area ratio of the drug to the internal standard and   Chemical Stability of New Acyclovir Analogues with Peptidomimetics  263 
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concentration was linear over the entire examined concentration range. The correlation 
coefficients of the calibration curves were greater than 0.997. For all of the examined 
compounds the coefficient of variation calculated for the six analysed samples did not 
exceed 5%. 
Hydrolysis of acyclovir esters with thiazole rings containing amino acids (Gly, Ala, Val, 
Leu) was studied at pH 1.0 (HCl) and pH 7.4 (phosphate buffered saline). Stock solutions 
of the prodrugs were prepared and used immediately for stability studies. Aliquots (9.8 ml) 
of the buffer were placed in a screw-capped vial and allowed equilibrate at 37°C. A 
prodrug stock solution (0.2 ml) was added to the buffer. The vial was placed in a constant 
shaker bath set at 37
oC and 60 rpm. Each sample was directly analysed by HPLC. 
Conclusion 
The chemical stability of acyclovir esters with peptidomimetics was studied under 
experimental conditions simulating some relevant biological media (pH 1.0 and pH 7.4, 
37°C). The examined compounds were not stable in acidic media. This result was 
predictable, because the compounds are esters and esters easily undergo decomposition 
by hydrolysis in acidic media. The order of decreasing stability in neutral media and at a 
temperature of 37°C was 3>>2>4>1. Under the same conditions, the Boc-2-Val-thiazole-
acyclovir (3) was more stable than valacyclovir (t1/2 = 13 h), the first effective prodrug of 
acyclovir [4]. Boc-2-Val-thiazole-acyclovir (3) exhibit the highest chemical stability at 
pH  7.4 compared to the other examined compounds, but it did not exhibit a satisfying 
effect against HSV-1 or HSV-2 [5]. The compound Boc-2-Ala-thiazole-acyclovir (2) showed 
an appreciable effect against HSV-2 and exhibited satisfying chemical stability. The 
correlation with both biological activity and chemical stability suggests that the Boc-2-Ala-
thiazole-acyclovir (2) could be attractive for antiviral chemotherapy. 
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